drugset / Trial / NCT06906029
Abdominal aBscess Catheter Sclerotherapy (ABCS)
Phase 1/2
Not yet recruiting
60 enrolled
University of Alabama at Birmingham
Argon Medical Devices · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a single center, two arm phase I/II clinical trial exploring the use of chemical sclerosants (ethanol and povidone iodine) in decreasing the time needed for catheter drainage for patients with non-fistulous intraabdominal abscesses. The target study sample size is 60 patients, 30 in each arm and abscess size is to be a minimum of 3cm in all 3 dimensions. The primary outcomes of interest will be tolerability and need for catheter reinsertion by one week post intervention.
Timeline
- Start
- 2026-07
- Primary completion
- 2028-07
- Completion
- 2028-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Alcohol | Other / unclassified | — | Other |
| Comparator | Povidone-Iodine | Other / unclassified | — | Other |